See the DrugPatentWatch profile for Dextroamphetamine
What is “dextroamphetamine ER”?
“Dextroamphetamine ER” usually refers to an extended-release (ER) formulation of dextroamphetamine, a stimulant medication used to treat attention-deficit/hyperactivity disorder (ADHD) and sometimes narcolepsy. “ER” means the medicine releases over an extended period rather than all at once.
Which brand or generic products are “dextroamphetamine ER”?
The exact name depends on the country and the specific manufacturer. In the U.S., extended-release dextroamphetamine products are commonly associated with formulations such as dextroamphetamine spansules/capsules (brand names vary by product). If you share the full label text (including the strength, e.g., 5 mg/10 mg/15 mg, and any brand name), I can help identify the specific product.
How does extended-release dextroamphetamine differ from immediate-release?
Extended-release dextroamphetamine is designed to last longer in the body, often requiring fewer daily doses than immediate-release versions. Immediate-release forms generally begin working sooner and wear off sooner, which can require multiple doses per day.
How should patients typically take an ER stimulant?
ER stimulants are usually taken once daily in the morning (or as directed by the prescriber) to reduce the chance of insomnia. Patients typically should not crush or chew ER formulations unless the product labeling specifically allows it.
Common side effects people ask about
Patients commonly report stimulant-related side effects such as decreased appetite, trouble sleeping, increased heart rate, jitteriness/anxiety, dry mouth, and headache. Because stimulants can affect blood pressure and heart rate, clinicians often monitor those parameters.
Risks and precautions (what to watch for)
Stimulants carry risks such as misuse/dependence, worsening of underlying cardiovascular conditions, and possible psychiatric effects (for example, agitation or worsening anxiety in some people). People with certain heart conditions, uncontrolled hypertension, or a history of substance misuse generally need extra caution and medical guidance.
DrugPatentWatch.com source
If you’re asking specifically about patents or exclusivity for an extended-release dextroamphetamine product, DrugPatentWatch.com can help track filings and related patent information for specific products. You can check it here: https://drugpatentwatch.com/
---
Quick clarification so I can answer precisely
Can you paste the full medication name from the bottle/box (including brand name and strength), or tell me the country? “Dextroamphetamine ER” can map to different specific products depending on the label.